Refine by
Colon Cancer Articles & Analysis
47 news found
Xilis, Inc., a pioneering company developing its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, announced today that breast cancer oncologist Daniel F. ...
Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. ...
We believe Check-Cap has the potential to reach those who are deterred by colonoscopy and to help improve colon cancer screening through a patient-friendly solution without the need of bowel cleaning, sedation, and fasting." ...
Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer. ...
The poster presentations come after Carina’s recent submission of a pre-IND package to the FDA for Carina’s LGR5 CAR-T cell for the treatment of patients with advanced colorectal cancer. Highlights Five conference abstracts will be presented as poster presentations at AACR in the immuno-oncology and preclinical immunotherapy sessions Four presentations describe ...
(Nasdaq: GH), a leading precision oncology company, today announced it will present data highlighting the clinical utility of its liquid biopsy tests in the treatment and management of early- to late-stage gastrointestinal cancers, including colorectal cancer, at the 2022 ASCO Gastrointestinal Cancers Symposium being held January 20-22, 2022. ...
“We know that colorectal cancer is the deadliest cancer for young Australians. We also know that there has been a nearly 190% increase in colorectal cancer cases in adolescents and young people in Australia over the last 30 years. ...
About the Oncotype DX and Oncotype MAP Portfolio of Tests The Oncotype DX portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumour in order to optimise cancer treatment decisions. In breast cancer, the Oncotype DX Breast Recurrence Score test is the only test ...
Proximie has teamed up with Vodafone to pilot the role of 5G in increasing the connectivity and performance of remote assistance and training in cancer care. Trial with the assistance of 5G in using Proxime to ‘scrub in’ clinicians is taking place at University Hospital of Wales and University Hospital Llandough. Trial will be used in the diagnosis and treatment of ...
Pittsburgh, PA – (April 30, 2021) – The Bladder Health Foundation announces the rollout of the first on-line patient registry for pelvic radiation cancer survivors. The online registry is located at www.radiationcystitis.com The Bladder Health Foundation, with support from Lipella Pharmaceuticals Inc., is promoting the awareness of a serious bladder health ...
Lipella Pharmaceuticals promotes awareness of hemorrhagic cystitis, a chronic painful syndrome that can be acquired by cancer patients who have received pelvic radiation therapy. PITTSBURGH, November 12, 2020 – During this November, Bladder Health Awareness Month, we promote the awareness of a serious bladder health condition, hemorrhagic cystitis, which affects many ...
August 1 marks World Lung Cancer Day -- a time to raise awareness of the need for increased lung cancer research and innovation. Anyone can get lung cancer. Here are the facts you need to know: Lung cancer is the leading cause of cancer deaths worldwide More patients die every year from lung ...
The CDx will be leveraged to identify ROS1-positive non-small cell lung cancer (NSCLC) patients who may be eligible for treatment with entrectinib (Rozlytrek). ...
Vitanova’s light-activated targeted cancer drug offers a cost effective and efficacious cancer therapy with the potential to eliminate unwanted side effects. ...
Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on ending deaths from cancer, today announced the closing of $2.25 million in seed round funding. ...
ByCalviri
At the AACR-NCI-EORTC conference for molecular targets (#Targets19) at Boston, we presented our latest preclinical research on treating colon cancer and boosting anti-PD-1 immunotherapy with our “targeted nutrient deprivation” ...
This is important because MSI-H status is associated with very favorable responses to checkpoint inhibitor immunotherapies. Today, only patients with cancers that have generally shown higher frequencies of MSI-H tumors (colon, endometrial and stomach) are routinely tested. ...
ByCalviri
They discovered that these CAR-T cells significantly slowed tumour growth in melanoma and colon cancer mouse models, and improved their survival without readily apparent side ...
ByIMAPAC
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries. ...
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines Promising cancer gene therapy programme using small interfering RNA (siRNA) Data from in vitro study published in PLOS journal Stratford-upon-Avon, UK, 13 May ...